Drugs / GSAO
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01147029 | Jan 2008 → Apr 2012 | cancer of unknown primary site | Cancer Research UK | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSAO | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01147029 ↗ |
| Route | Intravenous | “Patients receive angiogenesis inhibitor GSAO IV over 1 hour on days 1-5 and 8-12” NCT01147029 ↗ |